MentionFox
Home › funding signals › Linnaeus Therapeutics, Inc.
Company · SEC filings

Linnaeus Therapeutics, Inc. funding history

Linnaeus Therapeutics, Inc. has 8 Form D filings on record, from 2023-01-26 to 2026-04-02. Together its new offerings report $5.75M sold.

Funding historyFounders and team

What do you want to do with Linnaeus Therapeutics, Inc.?

Based
HADDONFIELD, NEW JERSEY
Industry group
Biotechnology
Filings
8
Raised (new offerings)
$5.75M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-04-02Amendment
first sale 2026-02-17
$4.99M$10MSEC filing
2026-03-31Amendment
first sale 2026-02-17
$4.89M$10MSEC filing
2026-03-13Amendment
first sale 2026-02-17
$4.79M$10MSEC filing
2026-02-27New offering
first sale 2026-02-17
$4.47M$10MSEC filing
2025-08-22New offering
first sale 2025-08-19
$1.27M$10MSEC filing
2024-12-26Amendment——SEC filing
2024-08-12Filing——SEC filing
2023-01-26Filing——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Linnaeus Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/linnaeus-therapeutics-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Linnaeus Therapeutics, Inc. funding history: 8 SEC filings, $5.75M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/linnaeus-therapeutics-inc